Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Charlotte Brierley


Wellcome Trust Clinical Research Fellow

Investigating the cellular and genetic landscape of myeloid neoplasms

I am a Wellcome Trust Clinical Research Fellow, working towards a DPhil in the haematopoietic stem cell biology group supervised by Prof Adam Mead and Dr Bethan Psaila. I am currently completing a visiting fellowship to Dr Elli Papaemmanuil’s group at Memorial Sloan Kettering Cancer Centre in New York. 

I completed my undergraduate degree in medical sciences at the University of Cambridge and subsequent clinical medical training at Oxford. After qualifying I was awarded an NIHR Academic Foundation post in Edinburgh, after which I returned to Oxford as an Academic Clinical Fellow, allowing me to continue my research work alongside completing clinical training in haematology. 

My research aims to understand how patients with acute myeloid leukaemia (AML) develop the disease, and why some respond to treatment better than others. My project uses single cell approaches to understand the genomic, proteomic and transcriptomic changes in blast-phase myeloproliferative neoplasms, a particularly aggressive type of AML. More widely, we hope that understanding the mechanisms of disease development, progression and response to therapy will lead to the identification of novel therapeutic targets to help patients with this disease.